Effect of asiaticoside on hypertrophic scar in the rabbit ear model

Journal of Cutaneous Pathology

Volumn 36, Issue 2, 2009, Pages 234-239

  Ju Lin, Xie ^a   Shao Hai, Qi ^a,c   Tian Zeng, Li ^a   Bin, Huang ^b   Jing Ming, Tang ^a   Ying Bin, Xu ^a   Xu Sheng, Liu ^a   Bin, Shu ^a   Hui Zhen, Liang ^a   Yong, Huang ^a  

^a First Affiliated Hospital   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASIATICOSIDE; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; EAR INJURY; FEMALE; HISTOPATHOLOGY; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; NONHUMAN; PROTEIN EXPRESSION; RABBIT; TREATMENT OUTCOME; WOUND HEALING;

ANIMALS; ANTI-INFECTIVE AGENTS; CICATRIX, HYPERTROPHIC; DISEASE MODELS, ANIMAL; EAR; FEMALE; GENE EXPRESSION REGULATION; RABBITS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRITERPENES;

EID: 58649096590     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01015.x     Document Type: Article

References (16)

1. Urioste SS, Arndt KA, Dover JS. Keloids and hypertropic scars: review and treatment strategies. Semin Cutan Med Surg 1999 18 : 159.
2. Widgerow AD, Chait LA, Stals PJ, et al. New innovations in scar management. Aesthetic Plast Surg 2000 24 : 227.
3. Shukla A, Rasik AM, Jain GK, et al. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol 1999 65 : 1.
4. Cheng CL, Guo JS, Luk J, et al. The healing effects of Centella extract and asiaticoside on acetic acid induced gastric ulcers in rats. Life Sci 2004 74 : 2237.
5. QI S, Xie J, Li T, et al. Effects of Asiaticoside on hypertrophic scars in a nude mice model. Chin J Burns 2000 16 : 53.
6. Zhang T, Rong XZ, Yang RH, et al. Effect of asiaticoside on the expression of transforming growth factor-beta mRNA and matrix metalloproteinases in hypertrophic scars. J South Med Univ 2006 26 : 67.
7. Morris DD, Zhao LL, Bolton L, Roth SI, Ladin DA, Mustoe TA. Acute and chronic models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 1997 100 : 674.
8. Saulis AS, Mogford JH, Mustoe TA, et al. Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg 2002 110 : 177 discussion 184.
9. Zhou LJ, Ono I, Kaneko F. Role of transforming growth factor-beta 1 in fibroblasts derived from normal and hypertrophic scarred skin. Arch Dermatol Res 1997 289 : 646.
10. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991 88 : 6642.
11. Padgett RW, Cho SH, Evangelista C. Smads are the central component in transforming growth factor-β signaling. Pharmacol Ther 1998 78 : 47.
12. Chiffer M, von Gersdorff G, Bitzer M, et al. Smad proteins and transforming growth factor-beta signaling. Kidney Int 2000 58 (Suppl S45.
13. Miyazono K. Positive and negative regulation of TGF-signaling. J Cell Sci 2003 113 : 1101.
14. Miyazono K. A new partner for inhibitory Smads. Cytokine Growth Factor Rev 2002 13 : 7.
15. PAN Shu, LI Tianzeng, LI Yeyang, et al. Effects of asiaticoside on cell proliferation and Smad signal pathway of hypertrophic scar fibroblasts. Chin J Reparative Reconstr Surg 2004 18 : 291.
16. Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000 19 : 1745.